Abstract
Radiolabelled white cell scanning is widely used to detect the presence of infection. We present a case of non-Hodgkin's lymphoma manifesting with signs and symptoms suggestive of infection, in which a technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO) white cell scan demonstrated high uptake in lymph nodes involved by lymphoma. Differential cell analysis showed preferential lymphocyte labelling. The classification and management of the disease were changed accordingly. Our findings suggest that a future role for99mTc-HMPAO labelled white cells in the assessment of disease activity of lymphoma should be investigated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gould AA, Kubner KF, Greenlaw RH. Ga-67 citrate imaging in malignant lymphoma: final report of cooperative group.J Nucl Med 1978; 19: 1013–1019.
Johnston C, Benua RS, Teates CD, et al. Gallium-67-citrate imaging in Hodgkin's disease: final report of cooperative group.J Nucl Med 1977; 18: 692–698.
Paul R. Comparisons of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.J Nucl Med 1987; 28: 288–292.
Okada J, Joshikawa K, Imazeki K, et al. Comparisons of fluorine-18 FDG and gallium-67 in malignant lymphoma.J Nucl Med 1990; 31: 888.
Hammersley PAG, McCready VR. Leucocyte labelling with frozen reconstituted Ceretec.Nucl Med Commun 1992; 13: 210.
Rosen PJ. Hodgkin's disease and malignant lymphoma. In: Casciato D, Lowitz BB, eds.Manual of clinical oncology, 2nd edn. Boston: Little, Brown and Co.; 1988: 305–343.
Jaffe ES, Zarate OA, Kingma DW, et al. The inter-relationship between Hodgkin's disease and non-Hodgkin's lymphoma.Ann Oncol 1994; 5 Suppl 1: 7–11.
Okada J, Yoshikawa K, Itami M, et al. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.J Nucl Med 1992; 33: 325–329.
Leskinen-Kallio S, Ruotsalainen U, Nagren K, Teras M, Joensuu H. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.J Nucl Med 1991; 32: 1211–1218.
Minn H, Joensuu H, Ahonen A, et al. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumours.Cancer 1988; 61: 1776–1781.
McDougall IR, Baumert JE, Lantieri RL. Evaluation of111In leukocyte whole body scanning.Am J Roentgenol 1979; 133: 849–854.
Balachandran S, Boyd CM, Husain MM, Schaefer RF, Shah HR, Bahjati K. Indium-111 leukocyte uptake in neoplasms.Clin Nucl Med 1987; 12: 920–924.
Hammersley PAG. Mixed leucocyte labelling with111In and99Tcm.Nucl Med Commun 1994; 15: 262.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
AL-Nahhas, A.M., Hjiyiannakis, P., Hammersley, P.A.G. et al. Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma. Eur J Nucl Med 22, 1453–1456 (1995). https://doi.org/10.1007/BF01791154
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01791154